2014
DOI: 10.1111/efp.12129
|View full text |Cite
|
Sign up to set email alerts
|

Recent observations of sooty bark disease of sycamore maple in Prague (Czech Republic) and the phylogenetic placement of Cryptostroma corticale

Abstract: Summary The anamorphic fungus Cryptostroma corticale (Xylariaceae) causing sooty bark disease (SBD) of Acer pseudoplatanus has been reported within the past decade in several European countries. In the last decade, severe drought conditions during summer also resulted in an outbreak of SBD in park areas in Prague (Czech Republic). Trees with the typical syndromes were recorded in four localities in Prague. Some trees were also located in the alluvial plain of the Vltava River with groundwater available all yea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
29
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 44 publications
(33 citation statements)
references
References 29 publications
(31 reference statements)
1
29
1
Order By: Relevance
“… records during the years 2005–2013, data from Koukol et al. ()/records in this study; ‐ not studied. …”
Section: Methodsmentioning
confidence: 92%
See 2 more Smart Citations
“… records during the years 2005–2013, data from Koukol et al. ()/records in this study; ‐ not studied. …”
Section: Methodsmentioning
confidence: 92%
“…The PCR products were purified using the Gel/PCR DNA Fragments Extraction Kit (Geneaid Biotech, Bade City, Taiwan) and sequenced in both directions by the Laboratory of DNA Sequencing (Faculty of Science, Charles University, Czech Republic). All sequences were manually edited and aligned with ITS/LSU rDNA sequences of C. corticale from GenBank (from Koukol et al., ) to confirm the identification.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…HG934108 Zhang et al (2006),Stadler et al (2014),Koukol et al (2015), Wendt et al (2018) Stadler et al (2013), Daranagama et al (2015), Wendt et al (2018) Kuhnert et al (2014), Kuhnert et al (2017), Wendt et al (2018) Kuhnert et al (2014), Kuhnert et al (2017), Wendt et al (2018) Bitzer et al(2008),Kuhnert et al (2014),Wendt et al (2018Wendt et al ( ) et al (2016,Wendt et al (2018) …”
mentioning
confidence: 99%
“…Innovative drugs play the important role on promoting the progress of medicine and medical treatments. However, the traditional evaluation method of innovative drugs is a time consuming process, and has a lot of defects such as limited samples, poor timeliness, inefficiency, and the influence of uncertainty factors, especially in the face of sudden outbreak of diseases [13].…”
Section: Discussionmentioning
confidence: 99%